BPL MedTech unveils new ICU ventilator BPL Vent 300
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
The ventilator features a high-performance turbine capable of delivering up to 240 L/min peak flow
Following the completion of the acquisition on June 3, Noctrix’s flagship product, Nidra will become part of ResMed’s broader sleep medicine portfolio
The move signals a major expansion in access to next-generation weight-loss therapies
Juneja brings more than three decades of experience in pharmaceutical sales and marketing
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
DCGI-approved semaglutide syringes for diabetes and obesity expand treatment choices and improve affordability
The transaction includes an upfront payment of $1.55 billion, along with up to $1.1 billion in regulatory and commercial milestone payments
First-in-class treatment of life-threatening, drug-resistant Acinetobacter baumannii infections advancing toward Phase II clinical proof-of-concept
Regulatory clearance strengthens company’s global footprint and expands access to the Australian animal healthcare market
New PARTNER trial sub-study data show that post-operative ctDNA detection using tumour-informed MRD assays can accurately predict distant recurrence risk in triple-negative breast cancer patients
Subscribe To Our Newsletter & Stay Updated